Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-286,717
Closed -$18.7M 812
2017
Q1
$18.7M Buy
286,717
+9,167
+3% +$576K 0.91% 12
2016
Q4
$17.4M Buy
+277,550
New +$16.9M 1.4% 9
2016
Q3
Sell
-26,784
Closed -$1.66M 589
2016
Q2
$1.66M Sell
26,784
-285,699
-91% -$17.4M 0.1% 242
2016
Q1
$17.8M Buy
312,483
+243,494
+353% +$13.6M 1.23% 8
2015
Q4
$4.09M Buy
68,989
+38,080
+123% +$2.19M 0.28% 88
2015
Q3
$1.68M Buy
+30,909
New +$2.01M 0.1% 257
2015
Q2
Sell
-199,016
Closed -$11.7M 862
2015
Q1
$11.7M Buy
199,016
+195,796
+6,081% +$11.8M 0.71% 17
2014
Q4
$211K Buy
+3,220
New +$203K 0.02% 580
2014
Q2
Sell
-40,252
Closed -$2.07M 743
2014
Q1
$2.07M Buy
40,252
+16,685
+71% +$843K 0.36% 71
2013
Q4
$1.25M Buy
23,567
+272
+1% +$13.4K 0.16% 167
2013
Q3
$1.04M Sell
23,295
-4,721
-17% -$209K 0.19% 131
2013
Q2
$1.16M Buy
+28,016
New +$1.23M 0.17% 145

Other funds holding ABBV

Airain Ltd's ABBV Position: Q2 2017 in Review

Airain Ltd sold out of AbbVie (ABBV) in Q2 2017, closing a stake of 286,717 shares — an estimated $18.7M sold.

Airain Ltd first reported a position in ABBV in Q2 2013 and held it in 12 quarters. The position peaked at $18.7M in Q1 2017. 1,763 funds tracked by Wall St. Rank hold ABBV as of Q2 2017.

  • Airain Ltd reported no remaining AbbVie position as of Q2 2017 after selling out during the quarter.
  • Airain Ltd sold 286,717 AbbVie shares in Q2 2017, an estimated $18.7M.
  • Airain Ltd first reported a position in AbbVie in Q2 2013 and held it in 12 quarters.
  • Airain Ltd's AbbVie position peaked at $18.7M in Q1 2017.
  • 1,763 funds tracked by Wall St. Rank held AbbVie as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.